Follow on Google News News By Tag * Prescription * Sanofi-aventis * Pharmaceutical * Pharmavitae * Diversified * Generic * Pharma * Taxotere * Exposure * Vaccine * More Tags... Industry News News By Place Country(s) Industry News
Follow on Google News | Sanofi-Aventis: PharmaVitae Profile: New research report available at Fast Market ResearchRecently published research from Datamonitor, "Sanofi-Aventis: PharmaVitae Profile", is now available at Fast Market Research
This analysis examines the historical and forecast performance for Sanofi-Aventis in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. Features and benefits * Gain insight into Sanofi-Aventis's strategic outlook across the next 6 years.* Analyze company sales forecasts by product, therapy area, lifecycle stage, geography, molecule type and source. Highlights Strategic insight into the prospects for Sanofi-Aventis over the next six years. Picking out key strengths, weaknesses, opportunities and threats and evaluating the company's prescription pharmaceuticals outlook using a variety of cuts of the historical and forecast sales. Your key questions answered ------------------------------------------------------------ Full Report Details at - http://www.fastmr.com/ ------------------------------------------------------------ * Benchmark Sanofi-Aventis's performance against key rivals in the prescription pharmaceutical sector.* Analyse the positioning of the company as a diversified healthcare player with an enhanced focus on the vaccine, generic and consumer markets.* Assess how the genericization of blockbusters Plavix, Eloxatine, Taxotere, Stilnox/Ambien and Lovenox is expected to significantly impact growth. Report Table of Contents: Executive Summary Key findings Prescription pharmaceutical sales and growth rate performance, 2003- Financial performance, 2003- Sanofi-Aventis: Strategic insight Diversification will struggle to address near-term impact of generic exposure SWOT analysis Strengths Weaknesses Opportunities Threats ABOUT THIS PROFILE PharmaVitae Explorer database Chapter structure Quarterly update Company introduction Company sales Company financials Key products Data sourcing Analyst consensus QUARTERLY UPDATE Latest quarterly sales Latest quarterly financial analysis Q3 Q2 Latest comment Q4 Q1 Q4 Q3 Q2 Latest prescription pharma product news Q4 Q3 Q2 Q1 Q4 Latest corporate news Q4 Q3 Q2 Q1 Q4 Future product milestones COMPANY INTRODUCTION Key findings M&A history Sanofi-SynthElabo: Aventis: result of Hoechst and Rhone-Poulenc merger Sanofi-Aventis: Subsequent M&A promotes diversified business model M&A strategy a) Dilution of exposure to patent expiry risk across blockbuster portfolio b) Establish a diversified business model c) Creation of industry-leading player in the global thrombosis market d) Expansion of geographic presence Current corporate structure COMPANY SALES Key findings Prescription pharmaceutical sales and growth rate analysis, 2003- Product analysis Product analysis, 2003- Product analysis, 2009- Therapy area analysis Geographic analysis Launch/core/ Explanation of launch/core/ Launch analysis, 2009- Core analysis, 2009- Expiry analysis, 2009- Generics analysis, 2009- Launch/core/ Molecule type analysis Externalization analysis COMPANY FINANCIALS Key findings Reconciliation between PharmaVitae- Operating costs and profit analysis Operating costs and profit analysis, 2003- Operating cost ratio and profit margin analysis, 2003- Operating cost ratio and profit margin analysis, 2009- Operating costs and profit analysis, 2009- KEY PRODUCTS Key findings Overview Lantus Vaccines aflibercept Lovenox Plavix Aprovel/CoAprovel Taxotere Eloxatine APPENDIX References Abbreviations Exchange rates About Datamonitor The Datamonitor Group is a world-leading provider of premium global business information, delivering independent data, analysis and opinion across the Automotive, Consumer Markets, Energy & Utilities, Financial Services, Logistics & Express, Pharmaceutical & Healthcare, Retail, Technology and Telecoms industries. Datamonitor's market intelligence products and services ensure that you will achieve your desired commercial goals by giving you the insight you need to best respond to your competitive environment. View more research from Datamonitor at http://www.fastmr.com/ About Fast Market Research Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156. # # # Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|